Dr Kelvin Teo

Adjunct A/Prof. Teo is a renowned general ophthalmologist, cataract surgeon, and senior consultant at Advanced Eye Clinic and Surgery, with a global reputation in the management of retinal and aging eye conditions. With decades of clinical and research experience, he offers personalized, evidence-based care for patients with a wide range of eye disorders, including age-related macular degeneration (AMD), diabetic eye disease, retinal vascular conditions, and other degenerative changes of the aging eye.

Dr. Teo is at the forefront of innovation in ophthalmology, with access to cutting-edge therapies and diagnostic tools due to his recognized status as a global key opinion leader (KOL) in the field of medical retina. His expertise allows patients to benefit from the latest advancements, including novel treatments for AMD, diabetic retinopathy, and other retinal diseases that would otherwise be unavailable outside of specialized centers.

Dr. Teo is deeply committed to improving his patients’ quality of life by offering tailored, evidence-based treatments.

His clinical expertise extends to the management of complex retinal conditions, including select surgical procedures, although his primary focus remains on non-surgical and minimally invasive treatments.

His expertise enables him to provide advanced solutions for conditions ranging from common issues like cataracts to complex retinal diseases such as AMD.

With access to the latest therapies and diagnostic tools, Dr. Teo ensures his patients receive the most effective and innovative care available. His dedication to treating aging eye conditions and providing comprehensive, minimally invasive management has solidified his reputation as a trusted leader in ophthalmology and a global authority in AMD and retina-related disorders.

Dr. Teo graduated from Barts and the London School of Medicine and Dentistry and completed his ophthalmology specialist training at the Singapore National Eye Centre (SNEC), where he practiced for over a decade.

He pursued two prestigious fellowships in Medical Retina—one at SNEC and another at Sydney Eye Hospital, University of Sydney. During his time in Sydney, he also earned a PhD in Medical Research, further solidifying his expertise in the field.

During his tenure at SNEC and the Singapore Eye Research Institute (SERI), Dr. Teo made significant contributions in both clinical care and research leadership:

• Clinical Director, SNEC Ocular Reading Centre: He played a pivotal role in the National Diabetic Eye Screening initiative (Singapore Integrated Diabetic Retinopathy Programme).

• Director, Clinical Trials Platform, SERI: He oversaw the design, conduct, and management of groundbreaking clinical studies.

• As a clinical scientist at SERI, his research focused on the aging eye and AMD. Dr. Teo has authored over 100 peer-reviewed publications and secured more than SGD 5 million in research funding, including the prestigious National Medical Research Council (NMRC) Transition Award.

Dr. Teo continues to advance the field of ophthalmology as:

• Adjunct Associate Professor at the Ophthalmology & Visual Sciences Academic Clinical Programme (EYE ACP), Duke-NUS Medical School.

• Visiting Clinician Scientist to the Singapore Eye Research Institute (SERI).

In addition, he collaborates with pharmaceutical and diagnostic imaging companies globally, advising on the development of innovative therapies and cutting-edge diagnostic technologies for retinal diseases. His global standing as a KOL allows him to remain at the forefront of medical retina advancements and bring these innovations to his patients.